After an 11th hour deal struck for the next European Union budget by its 27 members on 10th December 2020, Horizon Europe, the EU’s latest research and innovation investment programme can at last be launched next month. Originally touted at…
The festive season is upon us and for all our dear friends, partners, collaborators and colleagues, we wish that the roller coaster ride that has been 2020, comes to an end and that we all have some time to relax.…
Imagine a nature-inspired technology that can increase your life expectancy. One that can prevent or delay the onset of chronic diseases like diabetes, cancer and heart diseases. How would it feel if we could help in early and efficient medical…
Mission-driven companies, also known as “profit-with-purpose corporations”, became over the past years a powerful trend when it comes to innovative business models. Until recently companies have mainly focused on maximizing Total Shareholder Return (TSR) and profits, quite understandably. Today, under…
An excellent new article from our founder Aurore, about what social impact means and how it's applied, when it comes to startups and entrepreneurs. The in-depth review by George Serafeim on the Harvard Business Review provides a great frame of thought for looking at ESG (Environmental, Social Governance) data…
Dear Clients, Colleagues and Friends, Azapharm Team wishes you a bright and blessed Jewish New Year. May this year be made of happiness and success!
AZAPHARM congratulates the first 5 winners of the DARE Contest. The first 2015 edition of the DARE contest organized by the FrenchTech, for French and Israeli life sciences start-ups specializing in personalized medicine, took place on December 9th in Paris.…
A new generation life-sciences consulting company Azapharm dedicates itself to organizations within the healthcare industry who seek specialized and experienced support at the key stages of the development of their products or services. The company is composed of a collaborative…